|
JP6535430B2
(ja)
*
|
2012-09-28 |
2019-06-26 |
イグニタ、インク. |
非定型プロテインキナーゼcのアザキナゾリン阻害薬
|
|
AU2014249233A1
(en)
|
2013-03-13 |
2015-09-24 |
The Regents Of The University Of Michigan |
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
USRE49687E1
(en)
|
2014-09-09 |
2023-10-10 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
US10526341B2
(en)
*
|
2014-11-19 |
2020-01-07 |
Memorial Sloan-Kettering Cancer Center |
Thienopyrimidines and uses thereof
|
|
WO2016197027A1
(en)
*
|
2015-06-04 |
2016-12-08 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with mll proteins
|
|
TWI703150B
(zh)
*
|
2015-06-04 |
2020-09-01 |
美商庫拉腫瘤技術股份有限公司 |
用於抑制menin及mll蛋白之交互作用的方法及組合物
|
|
GB201519573D0
(en)
|
2015-11-05 |
2015-12-23 |
King S College London |
Combination
|
|
AU2017212572A1
(en)
*
|
2016-01-26 |
2018-08-23 |
Memorial Sloan-Kettering Cancer Center |
Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia
|
|
US10752639B2
(en)
|
2016-03-16 |
2020-08-25 |
Kura Oncology, Inc. |
Bridged bicyclic inhibitors of menin-MLL and methods of use
|
|
WO2017161028A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Kura Oncology, Inc. |
Substituted inhibitors of menin-mll and methods of use
|
|
CN109415337B
(zh)
|
2016-05-02 |
2022-01-18 |
密执安大学评议会 |
作为多发性内分泌腺瘤蛋白抑制剂的哌啶
|
|
WO2017207387A1
(en)
|
2016-05-31 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Spiro condensed azetidine derivatives as inhibitors of the menin-mml1 interaction
|
|
ES2831084T3
(es)
*
|
2016-06-10 |
2021-06-07 |
Vitae Pharmaceuticals Inc |
Inhibidores de la interacción menina-MLL
|
|
WO2018024602A1
(en)
|
2016-08-04 |
2018-02-08 |
Bayer Aktiengesellschaft |
2,7-diazaspiro[4.4]nonanes
|
|
AU2017326487B2
(en)
|
2016-09-14 |
2021-08-05 |
Janssen Pharmaceutica Nv |
Spiro bicyclic inhibitors of menin-MLL interaction
|
|
CA3033239A1
(en)
|
2016-09-14 |
2018-03-22 |
Janssen Pharmaceutica Nv |
Spiro bicyclic inhibitors of menin-mll interaction
|
|
TWI753016B
(zh)
*
|
2016-09-14 |
2022-01-21 |
比利時商健生藥品公司 |
Menin-mll相互作用之稠合二環抑制劑
|
|
US12084462B2
(en)
|
2016-09-14 |
2024-09-10 |
Janssen Pharmaceutica Nv |
Spiro bicyclic inhibitors of menin-MLL interaction
|
|
EA039109B1
(ru)
*
|
2016-12-07 |
2021-12-06 |
Кура Онколоджи, Инк. |
Мостиковые бициклические ингибиторы взаимодействия менин-mll и способы применения
|
|
KR102513564B1
(ko)
*
|
2016-12-15 |
2023-03-22 |
얀센 파마슈티카 엔.브이. |
메닌-mll 상호작용의 아제판 억제제
|
|
EA201991448A1
(ru)
|
2017-01-06 |
2019-12-30 |
Янссен Фармацевтика Нв |
Азепановые ингибиторы взаимодействия менин-mll
|
|
EA038388B1
(ru)
*
|
2017-01-16 |
2021-08-19 |
Кура Онколоджи, Инк. |
Замещенные ингибиторы менина-mll и способы применения
|
|
CN110691779B
(zh)
*
|
2017-03-24 |
2023-10-10 |
库拉肿瘤学公司 |
治疗血液系统恶性肿瘤和尤因肉瘤的方法
|
|
EP3600313A4
(en)
|
2017-03-31 |
2020-09-23 |
The Regents of The University of Michigan |
PIPERIDINES AS COVALENT MENINE INHIBITORS
|
|
US11542248B2
(en)
|
2017-06-08 |
2023-01-03 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
|
TW201920170A
(zh)
*
|
2017-09-20 |
2019-06-01 |
美商庫拉腫瘤技術股份有限公司 |
經取代之menin-mll 抑制劑及使用方法
|
|
US11396517B1
(en)
|
2017-12-20 |
2022-07-26 |
Janssen Pharmaceutica Nv |
Exo-aza spiro inhibitors of menin-MLL interaction
|
|
JP7307729B2
(ja)
*
|
2017-12-20 |
2023-07-12 |
ヤンセン ファーマシューティカ エヌ.ベー. |
メニン-mll相互作用のエキソ-アザスピロ阻害剤
|
|
CN110204552B
(zh)
*
|
2018-02-28 |
2021-08-17 |
中国科学院上海药物研究所 |
一类噻吩并[3,2-d]嘧啶衍生物、其制备方法、药物组合物与用途
|
|
CR20200464A
(es)
|
2018-03-08 |
2021-04-14 |
Incyte Corp |
Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
|
|
CN112105621B
(zh)
*
|
2018-03-30 |
2024-02-20 |
住友制药株式会社 |
光学活性桥型环状仲胺衍生物
|
|
WO2020010003A1
(en)
|
2018-07-02 |
2020-01-09 |
Incyte Corporation |
AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
|
|
US12662494B2
(en)
|
2018-08-08 |
2026-06-23 |
Sumitomo Pharma Co., Ltd. |
Optically active bridged piperidine derivative
|
|
EP3860978A1
(en)
|
2018-10-03 |
2021-08-11 |
The Regents Of The University Of Michigan |
Small molecule menin inhibitors
|
|
WO2020085504A1
(ja)
|
2018-10-26 |
2020-04-30 |
大鵬薬品工業株式会社 |
光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
|
|
CA3116141C
(en)
*
|
2018-12-06 |
2023-09-05 |
Daiichi Sankyo Company, Limited |
Cycloalkane-1,3-diamine derivative
|
|
ES2974634T3
(es)
|
2018-12-21 |
2024-06-28 |
Celgene Corp |
Inhibidores de tienopiridinas de RIPK2
|
|
ES2991429T3
(es)
*
|
2019-02-01 |
2024-12-03 |
Univ South Carolina |
Compuestos de piridina bicíclicos para su uso en el tratamiento del cáncer
|
|
BR112021024108A2
(pt)
|
2019-05-31 |
2022-03-22 |
Ikena Oncology Inc |
Inibidores de tead e usos dos mesmos
|
|
US11458149B1
(en)
|
2019-05-31 |
2022-10-04 |
Ikena Oncology, Inc. |
TEAD inhibitors and uses thereof
|
|
CN112116960B
(zh)
*
|
2019-06-20 |
2024-10-11 |
中国石油化工股份有限公司 |
柴油加氢反应的组分含量确定方法、装置
|
|
TW202126636A
(zh)
|
2019-09-30 |
2021-07-16 |
美商阿吉歐斯製藥公司 |
作為menin抑制劑之六氫吡啶化合物
|
|
MD4051678T2
(en)
|
2019-10-28 |
2026-07-31 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of the KRAS G12C mutant
|
|
WO2021085653A1
(en)
|
2019-10-31 |
2021-05-06 |
Taiho Pharmaceutical Co., Ltd. |
4-aminobut-2-enamide derivatives and salts thereof
|
|
EP4067343A4
(en)
|
2019-11-29 |
2024-01-03 |
Taiho Pharmaceutical Co., Ltd. |
NEW PHENOLIC COMPOUND OR SALT THEREOF
|
|
WO2021106231A1
(en)
*
|
2019-11-29 |
2021-06-03 |
Taiho Pharmaceutical Co., Ltd. |
A compound having inhibitory activity against kras g12d mutation
|
|
UY38988A
(es)
|
2019-12-19 |
2021-06-30 |
Janssen Pharmaceutica Nv |
Derivados espiráncos sustituidos de cadena lineal
|
|
CN111297863B
(zh)
*
|
2020-03-30 |
2021-06-25 |
四川大学华西医院 |
menin-MLL抑制剂在制备治疗子宫内膜癌的药物中的应用
|
|
IL297039A
(en)
|
2020-04-07 |
2022-12-01 |
Syndax Pharmaceuticals Inc |
Combinations of menin inhibitors and cyp3a4 inhibitors and methods of use thereof
|
|
WO2021204159A1
(en)
|
2020-04-08 |
2021-10-14 |
Agios Pharmaceuticals, Inc. |
Menin inhibitors and methods of use for treating cancer
|
|
TW202204334A
(zh)
|
2020-04-08 |
2022-02-01 |
美商阿吉歐斯製藥公司 |
Menin抑制劑及治療癌症之使用方法
|
|
WO2021215544A1
(en)
|
2020-04-24 |
2021-10-28 |
Taiho Pharmaceutical Co., Ltd. |
Kras g12d protein inhibitors
|
|
US12702658B2
(en)
|
2020-04-24 |
2026-08-11 |
Taiho Pharmaceutical Co., Ltd. |
Anticancer combination therapy with N-(1-acryloyl-azetidin-3-yl)-2-((1H-indazol-3-yl)amino)methyl)-1H-imidazole-5-carboxamide inhibitor of KRAS-G12C
|
|
AR122159A1
(es)
*
|
2020-05-28 |
2022-08-17 |
Novartis Ag |
Inhibidores de mll1 y agentes antineoplásicos
|
|
EP4232020A4
(en)
*
|
2020-10-21 |
2024-08-07 |
Kura Oncology, Inc. |
Treatment of hematological malignancies with inhibitors of menin
|
|
WO2022109487A1
(en)
|
2020-11-23 |
2022-05-27 |
Merck Sharp & Dohme Corp. |
Spirocyclic-substituted 6,7-dihydro-pyrano[2,3-d]pyrimidine inhibitors of kras g12c mutant
|
|
BR112023021040A2
(pt)
|
2021-05-08 |
2024-02-06 |
Janssen Pharmaceutica Nv |
Derivados espiro substituídos
|
|
EP4334310A1
(en)
|
2021-05-08 |
2024-03-13 |
JANSSEN Pharmaceutica NV |
Substituted spiro derivatives
|
|
AR125866A1
(es)
|
2021-05-14 |
2023-08-23 |
Syndax Pharmaceuticals Inc |
Inhibidores de la interacción de menina-mll
|
|
CA3218479A1
(en)
|
2021-06-01 |
2022-12-08 |
Wei Cai |
Substituted phenyl-1h-pyrrolo[2, 3-c]pyridine derivatives
|
|
WO2022253289A1
(en)
|
2021-06-03 |
2022-12-08 |
Janssen Pharmaceutica Nv |
Pyridazines or 1,2,4-triazines substituted by spirocyclic amines
|
|
AU2022292697A1
(en)
|
2021-06-17 |
2024-02-01 |
Janssen Pharmaceutica Nv |
(r)-n-ethyl-5-fluoro-n-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-methylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt for the treatment of diseases such as cancer
|
|
WO2023011446A1
(zh)
*
|
2021-08-04 |
2023-02-09 |
成都苑东生物制药股份有限公司 |
一种新型磺酰胺类menin-MLL相互作用抑制剂、其制备方法及医药用途
|
|
WO2023056589A1
(en)
|
2021-10-08 |
2023-04-13 |
Servier Pharmaceuticals Llc |
Menin inhibitors and methods of use for treating cancer
|
|
US20250074910A1
(en)
*
|
2021-12-31 |
2025-03-06 |
Hitgen Inc. |
Menin inhibitor and use thereof
|
|
WO2023215354A1
(en)
*
|
2022-05-03 |
2023-11-09 |
Board Of Regents, The University Of Texas System |
Menin proteolysis targeting chimeras (protacs)
|
|
US20260151399A1
(en)
|
2022-11-24 |
2026-06-04 |
Oryzon Genomics, S.A. |
Combinations of lsd1 inhibitors and menin inhibitors for treating cancer
|
|
CN116199633B
(zh)
*
|
2022-12-27 |
2024-05-31 |
甘肃省化工研究院有限责任公司 |
一种制备瑞维鲁胺的方法
|
|
AR132185A1
(es)
|
2023-03-24 |
2025-06-04 |
Acerta Pharma Bv |
COMPUESTOS DE 1-H-PIRROLO[2,3-c]PIRIDINA
|
|
KR20260096846A
(ko)
|
2023-10-20 |
2026-06-24 |
머크 샤프 앤드 돔 엘엘씨 |
Kras 단백질의 소분자 억제제
|